山东省副省长孙继业调研中医药工作:提高山东中医药在全国的影响力和竞争力

2018-07-10 陈计智 中国中医

山东省副省长孙继业到山东省中医药研究院附属医院、山东中医药大学附属医院调研中医药工作。

山东省副省长孙继业到山东省中医药研究院附属医院、山东中医药大学附属医院调研中医药工作。

在山东省中医药研究院附属医院,孙继业实地考察了中药房、针灸推拿中心、金伟国家名老中医工作室、名中医药专家诊区、预防保健中心及保健病房。在山东中医药大学附属医院,孙继业察看了医院中医药文化浮雕、中药材、自制剂展示,并来到院史馆全面了解医院建设发展历程及历代名老中医药专家,实地考察了针灸科门诊、周围血管科病房及治未病中心,仔细察看了各种中医特色疗法,了解了周围血管疾病的中医诊疗优势及中医治未病干预手段。

孙继业强调,要加快中医医院改革发展,狠抓中医人才队伍建设,探索有利于中医药特色优势发挥的体制机制,创新中医药健康服务的新模式、新业态、新领域,让中医医院更有活力和生命力。要加快中医药振兴步伐,推动中医药产业融合发展,提高山东中医药在全国的影响力和竞争力,为医养健康产业强省建设作出积极贡献。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1908107, encodeId=f96d190810e7e, content=<a href='/topic/show?id=96334e74810' target=_blank style='color:#2F92EE;'>#山东省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47748, encryptionId=96334e74810, topicName=山东省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Sun Sep 02 04:52:00 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764674, encodeId=cba91e646748a, content=<a href='/topic/show?id=d5cee56412b' target=_blank style='color:#2F92EE;'>#竞争力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75641, encryptionId=d5cee56412b, topicName=竞争力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693637755061, createdName=12498cbcm12(暂无昵称), createdTime=Wed Feb 20 22:52:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751461, encodeId=d0bf1e514612d, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Fri Sep 14 13:52:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947117, encodeId=664f194e11732, content=<a href='/topic/show?id=2ac250319fe' target=_blank style='color:#2F92EE;'>#影响力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50319, encryptionId=2ac250319fe, topicName=影响力)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Tue Feb 05 02:52:00 CST 2019, time=2019-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409625, encodeId=48cf14096253b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Jul 12 04:52:00 CST 2018, time=2018-07-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1908107, encodeId=f96d190810e7e, content=<a href='/topic/show?id=96334e74810' target=_blank style='color:#2F92EE;'>#山东省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47748, encryptionId=96334e74810, topicName=山东省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Sun Sep 02 04:52:00 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764674, encodeId=cba91e646748a, content=<a href='/topic/show?id=d5cee56412b' target=_blank style='color:#2F92EE;'>#竞争力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75641, encryptionId=d5cee56412b, topicName=竞争力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693637755061, createdName=12498cbcm12(暂无昵称), createdTime=Wed Feb 20 22:52:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751461, encodeId=d0bf1e514612d, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Fri Sep 14 13:52:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947117, encodeId=664f194e11732, content=<a href='/topic/show?id=2ac250319fe' target=_blank style='color:#2F92EE;'>#影响力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50319, encryptionId=2ac250319fe, topicName=影响力)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Tue Feb 05 02:52:00 CST 2019, time=2019-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409625, encodeId=48cf14096253b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Jul 12 04:52:00 CST 2018, time=2018-07-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1908107, encodeId=f96d190810e7e, content=<a href='/topic/show?id=96334e74810' target=_blank style='color:#2F92EE;'>#山东省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47748, encryptionId=96334e74810, topicName=山东省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Sun Sep 02 04:52:00 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764674, encodeId=cba91e646748a, content=<a href='/topic/show?id=d5cee56412b' target=_blank style='color:#2F92EE;'>#竞争力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75641, encryptionId=d5cee56412b, topicName=竞争力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693637755061, createdName=12498cbcm12(暂无昵称), createdTime=Wed Feb 20 22:52:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751461, encodeId=d0bf1e514612d, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Fri Sep 14 13:52:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947117, encodeId=664f194e11732, content=<a href='/topic/show?id=2ac250319fe' target=_blank style='color:#2F92EE;'>#影响力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50319, encryptionId=2ac250319fe, topicName=影响力)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Tue Feb 05 02:52:00 CST 2019, time=2019-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409625, encodeId=48cf14096253b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Jul 12 04:52:00 CST 2018, time=2018-07-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1908107, encodeId=f96d190810e7e, content=<a href='/topic/show?id=96334e74810' target=_blank style='color:#2F92EE;'>#山东省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47748, encryptionId=96334e74810, topicName=山东省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Sun Sep 02 04:52:00 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764674, encodeId=cba91e646748a, content=<a href='/topic/show?id=d5cee56412b' target=_blank style='color:#2F92EE;'>#竞争力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75641, encryptionId=d5cee56412b, topicName=竞争力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693637755061, createdName=12498cbcm12(暂无昵称), createdTime=Wed Feb 20 22:52:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751461, encodeId=d0bf1e514612d, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Fri Sep 14 13:52:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947117, encodeId=664f194e11732, content=<a href='/topic/show?id=2ac250319fe' target=_blank style='color:#2F92EE;'>#影响力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50319, encryptionId=2ac250319fe, topicName=影响力)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Tue Feb 05 02:52:00 CST 2019, time=2019-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409625, encodeId=48cf14096253b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Jul 12 04:52:00 CST 2018, time=2018-07-12, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1908107, encodeId=f96d190810e7e, content=<a href='/topic/show?id=96334e74810' target=_blank style='color:#2F92EE;'>#山东省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47748, encryptionId=96334e74810, topicName=山东省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Sun Sep 02 04:52:00 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764674, encodeId=cba91e646748a, content=<a href='/topic/show?id=d5cee56412b' target=_blank style='color:#2F92EE;'>#竞争力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75641, encryptionId=d5cee56412b, topicName=竞争力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693637755061, createdName=12498cbcm12(暂无昵称), createdTime=Wed Feb 20 22:52:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751461, encodeId=d0bf1e514612d, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Fri Sep 14 13:52:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947117, encodeId=664f194e11732, content=<a href='/topic/show?id=2ac250319fe' target=_blank style='color:#2F92EE;'>#影响力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50319, encryptionId=2ac250319fe, topicName=影响力)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Tue Feb 05 02:52:00 CST 2019, time=2019-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409625, encodeId=48cf14096253b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Jul 12 04:52:00 CST 2018, time=2018-07-12, status=1, ipAttribution=)]
    2018-07-12 cathymary

相关资讯

山东省创建全国医养结合示范省工作方案

山东省政府办公厅印发《山东省创建全国医养结合示范省工作方案》。为全面实施新旧动能转换重大工程,统筹医疗卫生、养老服务及社会各方面资源,推动医养结合创新融合发展,制定本方案。

山东省卫生计生委发流感中医药防治方案,推出代茶饮方

2017年12月29日,山东省卫生计生委发布了《2017年山东省流感防控中医药应对方案》,其中提到从生活起居和中药处方、代茶饮方等方面,可有效应对流感。

又一省发文,取消医院、药店医保定点资格审查

凡法律法规未明令禁入的社会投资领域,都要向社会力量全面开放,鼓励新增服务和产品由社会力量提供。

医保结算放开?山东省明确54种高值药品双渠道购买

54种重大疾病治疗所需的高值药品,采取协议定点医疗机构和定点零售药店“双渠道”销售模式,并要求各地市要尽快将定点特药零售药店收费纳入医保结算系统,实现即时联网结算。

门诊中药处方不能低于60%,山东省对中医院提要求了

山东卫计委发文,对中医院人员配置和门诊处方提出了新要求。

山东省政府发布健康产业规划:建设6个中医药省级工程技术中心

山东省政府印发《山东省医养健康产业发展规划(2018-2022年)》。这是全国首个由省级卫生计生委牵头制定的健康产业规划,其中将中医药作为重点领域进行专题部署,提出建设6个中医药省级工程技术中心,培育60家规模以上中医药龙头企业。